Back to News
Market Impact: 0.4
Novartis AG Reports Q3 2026 Financial Results and Raises Full-Year Core Operating Income Guidance
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Novartis reported third-quarter 2026 net sales of USD 14.5 billion, up 4% year over year in both constant currencies and USD. Operating income fell 59% to USD 1.8 billion, while net income declined 70% to USD 1.2 billion. The supplied article text ends before explaining the profit declines.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
NVS-0.55
More News
- Tech's relief rally extends as attention turns to tough decisions for the Fed
- ‘Why do we value a Mars bar more than life-saving medicine?’ Sandoz CEO calls for level playing field with cheap Chinese antibiotics
- Who controls powerful AI? Anthropic has a plan for long after its leaders depart
- European shares fall as HSBC slump and energy fears offset AI glow
- Who’s really in charge at Anthropic after the IPO?
- SK Hynix Posts Record Profit Amid AI Rush